top of page

ICH guideline E17 on general principles for planning and design of multi-regional clinical trials -

With the increasing globalisation of drug development, it has become important that data from multi- regional clinical trials (MRCTs) can be accepted by regulatory authorities across regions and countries as the primary source of evidence to support marketing approval of drugs (medicinal products).

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page